These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 29341118)

  • 1. Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13.
    Luft O; Khattar R; Farrokhi K; Ferri D; Yavorska N; Zhang J; Sadozai H; Adeyi O; Chruscinski A; Levy GA; Selzner N
    Immunology; 2018 Jul; 154(3):476-489. PubMed ID: 29341118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
    Khattar R; Luft O; Yavorska N; Shalev I; Phillips MJ; Adeyi O; Gao D; Bartczak A; Urbanellis P; Shyu W; Zhang J; Manuel J; Levy GA; Selzner N
    PLoS One; 2013; 8(10):e72309. PubMed ID: 24146739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual LCMV antigen in transiently CD4
    Schweier O; Aichele U; Marx AF; Straub T; Verbeek JS; Pinschewer DD; Pircher H
    Eur J Immunol; 2019 Apr; 49(4):626-637. PubMed ID: 30636035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement.
    Richter K; Oxenius A
    Eur J Immunol; 2013 Sep; 43(9):2349-60. PubMed ID: 23749374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrogating Adaptive Immunity Using LCMV.
    Dangi T; Chung YR; Palacio N; Penaloza-MacMaster P
    Curr Protoc Immunol; 2020 Sep; 130(1):e99. PubMed ID: 32940427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.
    Straub T; Schweier O; Bruns M; Nimmerjahn F; Waisman A; Pircher H
    Eur J Immunol; 2013 Sep; 43(9):2338-48. PubMed ID: 23749409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRF9 Prevents CD8
    Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
    Clouthier DL; Zhou AC; Watts TH
    J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.
    Planz O; Ehl S; Furrer E; Horvath E; Bründler MA; Hengartner H; Zinkernagel RM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6874-9. PubMed ID: 9192659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection.
    Suresh M; Gao X; Fischer C; Miller NE; Tewari K
    J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
    Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vectored antibody gene delivery restores host B and T cell control of persistent viral infection.
    Ertuna YI; Fallet B; Marx AF; Dimitrova M; Kastner AL; Wagner I; Merkler D; Pinschewer DD
    Cell Rep; 2021 Nov; 37(9):110061. PubMed ID: 34852228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing immunity prevents virus-induced T-cell-mediated immunopathology in B cell-deficient mice.
    Straub T; Pircher H
    Eur J Immunol; 2019 May; 49(5):782-789. PubMed ID: 30793761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
    Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells.
    Matter MS; Hilmenyuk T; Claus C; Marone R; Schürch C; Tinguely M; Terracciano L; Luther SA; Ochsenbein AF
    PLoS One; 2011; 6(9):e24772. PubMed ID: 21966366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell STAT3 is required for the maintenance of humoral immunity to LCMV.
    McIlwain DR; Grusdat M; Pozdeev VI; Xu HC; Shinde P; Reardon C; Hao Z; Beyer M; Bergthaler A; Häussinger D; Nolan GP; Lang KS; Lang PA
    Eur J Immunol; 2015 Feb; 45(2):418-27. PubMed ID: 25393615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast Cells Modulate Antigen-Specific CD8
    Hackler Y; Siebenhaar F; Löhning M; Maurer M; Muñoz M
    Front Immunol; 2021; 12():688347. PubMed ID: 34194439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
    Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.